Title
Category
Credits
Event date
Cost
- Disease management
- Oncology
- 1.00 ACPE - Pharmacists
- 1.00 ACPE - Pharmacy Technicians
- 1.00 AMA - Physicians
- 1.00 ANCC - Nurses
- 1.00 APA - Psychologists
- 1.00 Attendance - General Attendance
- 1.00 ASWB - Social Workers
$0.00
This activity will explore advancements in chimeric antigen receptor (CAR) T-cell therapies in treating hematologic malignancies, particularly those of B-cell origin, with a focus on their efficacy and long-term outcomes.
- Disease management
- Oncology
- 0.75 ACPE - Pharmacists
- 0.75 ACPE - Pharmacy Technicians
- 0.75 AMA - Physicians
- 0.75 ANCC - Nurses
- 0.75 APA - Psychologists
- 0.75 Attendance - General Attendance
- 0.75 ASWB - Social Workers
$0.00
This activity will address the pivotal role of early detection in lung cancer and provide an in-depth look at the latest diagnostic advancements, including traditional methods and emerging technologies.
- Disease management
- Oncology
- 1.00 AMA - Physicians
- 1.00 ANCC - Nurses
- 1.00 Attendance - General Attendance
$0.00
This activity will provide an overview of the natural history of early-stage prostate cancer and review current data on the benefits and drawbacks of screening. It will discuss important aspects of diagnosis and describe evidence-based strategies for detection of early-stage prostate cancer.

Facebook
X
LinkedIn
Forward